11 Most Expensive Stocks Insiders Are Buying Recently

8. Tectonic Therapeutic, Inc. (NASDAQ:TECX)

Average price per share: $52.76

Market capitalization: $568.67 million

With an average price of $52.76 per share, Tectonic Therapeutic is the eighth among the 11 most expensive stocks insiders have bought recently. Tectonic Therapeutic is a biotechnology company engaged in the discovery and development of therapeutic proteins and antibodies that modulate the activity of G-protein coupled receptors (GPCRs).

With its proprietary technology platform GEODe, the company is working on new biological therapeutics to harness the human body to modify the course of disease. Tectonic’s main focus is on medical conditions where therapeutic options are limited or nonexistent. The company was co-founded by Timothy A. Springer and Andrew C. Kruse of Harvard Medical School.

On February 5, two insiders purchased a total of around $40.25 million worth of Tectonic Therapeutic shares at an average price of $52.76 per share. These transactions were part of the company’s $185 million private placement announced on February 3.

The stock is currently trading at $30.84, having lost 33.21% since the beginning of the year. Over the last 12 months, Tectonic Therapeutic returned 97.66% to its investors.

Five analysts have an average “Strong Buy” rating on Tectonic stock with a 12-month price target of $80.5 per share, according to data from Stock Analysis.